Anna Desmond, Fiona O'Halloran, Lesley Cotter, Colin Hill, & Des Field. (2022). Bioengineered Nisin A Derivatives Display Enhanced Activity against Clinical Neonatal Pathogens. MDPI AG.
Chicago Style (17th ed.) CitationAnna Desmond, Fiona O'Halloran, Lesley Cotter, Colin Hill, and Des Field. Bioengineered Nisin A Derivatives Display Enhanced Activity Against Clinical Neonatal Pathogens. MDPI AG, 2022.
MLA (9th ed.) CitationAnna Desmond, et al. Bioengineered Nisin A Derivatives Display Enhanced Activity Against Clinical Neonatal Pathogens. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.